Showing results (311-320 of 352) with videos related to

Sort By:
Pageof 36
Blood|July 13, 2023
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemiaJayastu Senapati, Samuel Urrutia, Sanam Loghavi, et al.
Spine|October 7, 2025
Preoperative Imaging Predictors of Postoperative C5 Palsy: A Comparative Study of MRI and Radiographic Imaging ModalitiesJonathan Dalton, Rachel Huang, Michael Carter, et al.
The Lancet. Haematology|August 18, 2018
Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trialTapan M Kadia, Jorge Cortes, Farhad Ravandi, et al.
Nature Reviews. Clinical Oncology|January 6, 2026
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncologyAmber Johnson, Yifei Shen, Xiaofeng Zheng, et al.
Hepatology (Baltimore, Md.)|March 15, 2024
Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice GuidelineKeyur Patel, Sumeet K Asrani, Maria Isabel Fiel, et al.
Haematologica|May 2, 2024
Outcomes and genetic dynamics of acute myeloid leukemia at first relapseAlex Bataller, Hagop Kantarjian, Alexandre Bazinet, et al.
Blood Cancer Journal|May 2, 2022
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AMLMusa Yilmaz, Hagop Kantarjian, Nicholas J Short, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2019
Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity ParadoxSanjaya K Satapathy, Yu Jiang, Uchenna Agbim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
American Journal of Hematology|November 15, 2017
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasmsRita Assi, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
Pageof 36